Alejandro Forner
Researcher Next ID · RN-028367
Researcher · Medicine
Madrid, Spain
- Works count
- 275
- Citation count
- 57,218
- H-index
- 52
- i10-index
- 108
Research interests
Publications
BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update
Journal of Hepatology · 2025 · https://doi.org/10.1016/j.jhep.2025.10.020
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Journal of Hepatology · 2022 · https://doi.org/10.1016/j.jhep.2021.12.010
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.11.018
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.
Journal for ImmunoTherapy of Cancer · 2021 · https://doi.org/10.1136/jitc-2021-003311
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Nature Reviews Gastroenterology & Hepatology · 2020 · https://doi.org/10.1038/s41575-020-0310-z
Hepatocellular carcinoma
The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)30010-2
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Journal of Hepatology · 2018 · https://doi.org/10.1016/j.jhep.2018.03.019
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
Cancer Treatment Reviews · 2010 · https://doi.org/10.1016/j.ctrv.2010.07.006
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
The Lancet Oncology · 2008 · 10.1016/s1470-2045(08)70284-5
Sorafenib in Advanced Hepatocellular Carcinoma
New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmoa0708857
Current projects
No projects listed.